Agents and Actions

, Volume 39, Supplement 1, pp C163–C165 | Cite as

Release of cell surface proteoglycan from chondrocytes by interleukin-1

  • R. L. Goldberg
  • S. Spirito
  • J. R. Doughty
  • G. Di Pasquale


A cell culture model was developed to assess factors that can protect cartilage from recombinant human interleukin-1α (IL-1)-induced breakdown. IL-1 (0.01–10 ng/ml) caused a dose-dependent release of cell surface proteoglycan into the medium of bovine and rabbit articular chondrocytes. Sulfated glycosaminoglycan (S-GAG) was detected in the medium and on the cell surface by a dimethlymethylene blue assay. The redistribution of the cell surface S-GAG to the medium compartment required protein synthesis because it was inhibited by cycloheximide and was time-dependent (>5 h). Although the release was most likely due tode novo synthesis of proteases, standard protease inhibitors failed to prevent the release even when used in combination. TGF-β and IGF-I increased the amount of S-GAG in both the medium and cell surface compartments, but did not protect from IL-1-induced release. This method has an advantage over a cartilage model of IL-1-induced matrix release because the drug and cytokine exposure time is reduced and the variability is less.


Cell Surface Protease Inhibitor Cycloheximide Glycosaminoglycan Culture Model 


  1. [1]
    J. T. Dingle, J. Saklatvala, R. M. Hembry, J. Tyler and H. B. Fell,A cartilage catabolic factor from synovium. Biochem. J.184, 177–180 (1979).PubMedGoogle Scholar
  2. [2]
    J. R. Hubbard, J. J. Steinberg, M. S. Bedar and C. B. Sledge,Effect of purified human interleukin-1 on cartilage degradation. J. Orthop. Res.6, 180–187 (1988).CrossRefPubMedGoogle Scholar
  3. [3]
    J. T. Dingle,The effect of synovial catabolin on cartilage synthetic activity. Conn. Tiss. Res.12, 277–286 (1984).Google Scholar
  4. [4]
    A. Ratcliffe, J. A. Tyler and T. E. Hardingham.,Articular cartilage cultured with interleukin 1. Increased release of link protein, hyaluronate-binding region and other proteoglycan fragments. Biochem. J.238, 571–580 (1986).PubMedGoogle Scholar
  5. [5]
    L. M. Kolibas and R. L. Goldberg,Effect of cytokines and anti-arthritic drugs on glycosaminoglycan synthesis by bovine articular chondrocytes. Agents and Actions27, 245–249 (1989).CrossRefPubMedGoogle Scholar
  6. [6]
    K. E. Kuettner, B. U. Pauli, G. Gall, V. A. Memoli and R. K. Shenk,Synthesis of cartilage matrix by mammalian chondrocytes in vitro. I. Isolation, culture characteristics and morphology. J. Cell Biol.93, 743–750 (1982).CrossRefPubMedGoogle Scholar
  7. [7]
    R. L. Goldberg and L. M. Kolibas,An improved method for determining proteoglycans synthesized by chondrocytes in culture. Conn. Tiss. Res.24, 265–275 (1990).Google Scholar

Copyright information

© Birkhäuser Verlag 1993

Authors and Affiliations

  • R. L. Goldberg
    • 1
  • S. Spirito
    • 1
  • J. R. Doughty
    • 1
  • G. Di Pasquale
    • 1
  1. 1.Research Department, Pharmaceuticals DivisionCIBA-GEIGY CorporationSummitUSA

Personalised recommendations